Cargando…
Myeloid zinc finger 1 mediates sulindac sulfide-induced upregulation of death receptor 5 of human colon cancer cells
A combined therapy of sulindac sulfide and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising strategy for the treatment of cancer. Sulindac sulfide had been shown to induce the expression of death receptor 5 (DR5), a receptor for TRAIL, and sensitize cancer cells to TRAI...
Autores principales: | Horinaka, Mano, Yoshida, Tatsushi, Tomosugi, Mitsuhiro, Yasuda, Shusuke, Sowa, Yoshihiro, Sakai, Toshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126006/ https://www.ncbi.nlm.nih.gov/pubmed/25102912 http://dx.doi.org/10.1038/srep06000 |
Ejemplares similares
-
Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells
por: Tanaka, Ryoichi, et al.
Publicado: (2015) -
Effect of Sulindac Sulfide on Metallohydrolases in the Human Colon Cancer Cell Line HT-29
por: Guillen-Ahlers, Hector, et al.
Publicado: (2011) -
Novel RAF/MEK inhibitor CH5126766/VS‐6766 has efficacy in combination with eribulin for the treatment of triple‐negative breast cancer
por: Ono, Hisako, et al.
Publicado: (2021) -
Discovery of cancer-preventive juices reactivating RB functions
por: Masuda, Mitsuharu, et al.
Publicado: (2023) -
Nutrient Availability Alters the Effect of Autophagy on Sulindac Sulfide-Induced Colon Cancer Cell Apoptosis
por: Chiou, Shiun-Kwei, et al.
Publicado: (2012)